Neurologic Disorder clinical trials

Explore recruiting neurologic disorder clinical trials.

Recruiting neurologic disorder studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neurologic Disorder trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Long-Term Follow-Up Protocol for Participants Previously Treated with KYV-101 (KYSA-4)

Germany

Phase II and Phase III (Integrated) EU CTIS Study details

Long-term Safety Outcomes in Patients Treated With Replimune Oncolytic Immunotherapy Products

Germany, Greece, France, Poland, Spain

Therapeutic use (Phase IV) EU CTIS Study details

Long Term Follow-Up of Patients Exposed to Lentiviral-Based CAR T-CellTherapy

Sweden, France, Finland, Netherlands, Austria, Norway +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Long-Term Follow-Up (LTFU) of Participants Treated with Adoptive Cell Therapies

Netherlands, Spain, Italy

Human Pharmacology (Phase I)- Other EU CTIS Study details

Long-term Follow-up study for relapsed/refractory (R/R) T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LL) patients previously treated with OC-1 cells.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Long-term Follow-up Study for Participants Previously Treated with Ciltacabtagene Autoleucel

Spain, Netherlands, Belgium, France

Therapeutic use (Phase IV) EU CTIS Study details

Neurologic Disorder trials by city

Neurologic Disorder in Toronto Neurologic Disorder in Vancouver Neurologic Disorder in Montreal Neurologic Disorder in Calgary Neurologic Disorder in Edmonton Neurologic Disorder in Ottawa Neurologic Disorder in Winnipeg Neurologic Disorder in Quebec City Neurologic Disorder in Hamilton Neurologic Disorder in Kitchener Neurologic Disorder in London Neurologic Disorder in Halifax Neurologic Disorder in New York Neurologic Disorder in Los Angeles Neurologic Disorder in Chicago Neurologic Disorder in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease